IL6 and lung carcinoma: Chen et al. showed that a two-single-nucleotide polymorphism (SNP) CC (-6331C and -572C) IL-6 promoter haplotype was significantly more common among cases than among controls in both groups, indicating this haplotype is associated with increased lung cancer risk [25].